loading
AIIMS Professor inaugurated DRUG DILIGENCE 2017 at Coimbatore

Dr Y K Gupta, Professor & Head of the Department of Pharmacology at All India Institute of Medical Sciences (AIIMS), New Delhi, who is also the National Scientific Co-ordinator of the Pharmacovigilance Programme of India (under the Ministry of Health & Family Welfare, Government of India) inaugurated DRUG DILIGENCE 2017, a National Level Conference & Workshop on Pharmacovigilance that was organized at IMA Hall, Coimbatore on 17th & 18th March 2017, an account of the 5th anniversary of Oviya MedSafe – a Coimbatore and London-based organization providing global pharmacovigilance consulting and drug safety services to the pharmaceutical industry. More than 250 delegates, most of them being doctors and pharmacists attended the conference.

Dr Y K Gupta was the Chief Guest and delivered a keynote address on ‘Evolution of Pharmacovigilance in India’. In his address, he spoke about different stages of drug development including molecular modelling, animal studies and phases of clinical trials and further explained how Adverse Drug Reactions should be identified and reported to drug regulatory authorities. He briefed about Periodic Safety Update Reports and Signal Detection. He elucidated on how benefit-risk balance of a medicinal product is assessed and answered the question on why India is using drugs which are banned in many other countries. Apart from sharing his perspectives on the overall safety of medicinal products, he highlighted that there is tremendous scope and lots of job opportunities in this field of Pharmacovigilance taking up which means genuine service to the mankind. He applauded Dr J Vijay Venkatraman, MD & CEO of Oviya MedSafe, that while pharmacovigilance is generally seen a dry discipline, Dr Vijay not only chose to found a company to offer pharmacovigilance service but also took the concept of pharmacovigilance to the masses, to the Indian Medical Association, to medical practitioners, and also to the students of Medicine, Pharmacy & Life Sciences, which clearly demonstrates Dr Vijay’s passion in pharmacovigilance as an important societal issue. He congratulated Oviya MedSafe for being the first in India to spread awareness among the masses about pharmacovigilance despite being a business entity. He wished Oviya MedSafe to continue to grow and reach further heights.

Dr N Shanthi, Professor & Head of the Department of Pharmacology, Coimbatore Medical College, Coimbatore was the Guest of Honour. In her address, she said that if the mind knows the eyes will see. She encouraged the students to get oriented with pharmacovigilance and choose it as a career opportunity. She expressed pride that Dr Vijay was her student and she appreciated him for taking the lead in promoting academia-industry collaboration in Pharmacovigilance, which is much needed for advancing the science further.

Ms Indu Nambiar, Senior Manager – Local Pharmacovigilance, Boehringer Ingelheim India Pvt Ltd, Mumbai, shared her perspective about the importance of having a robust pharmacovigilance system in place. She highlighted that the continuous improvement is the key for keeping quality in the drugs and pharmacovigilance plays a major role in enabling the product quality, which serves the general public in patient safety. She recalled her interactions with Dr Vijay on various professional forums about pharmacovigilance issues in India and appreciated his efforts in bringing together industry pharmacovigilance professionals for a dialogue with various policy-makers which is anticipated to result in more clarity on pharmacovigilance aspects and regulations for every stakeholder. She also commended all team members of Oviya MedSafe for the company’s excellent growth within its first 5 years and wished for the organization to grow further.

Ms Vasumathi Sriganesh, Honorary CEO, QMed Knowledge Foundation, Mumbai offered her felicitation. She highlighted the fact that how Pharmacovigilance as a discipline is a significant component of patient safety measures and encouraged students to take up the opportunity of learning and practise pharmacovigilance. She emphasized the fact that the expertise in publishing and searching medical & scientific literature for information on adverse drug effects in the right manner is very important for medical and pharmaceutical industry professionals alike, as such literature is both a source and outlet of safety data. She expressed immense happiness at Oviya MedSafe’s growth in the discipline of Pharmacovigilance in balance with their passionate scientific pursuit for Patient Safety.

Dr J Vijay Venkatraman, Managing Director and CEO of Oviya MedSafe, spoke about the journey of Oviya MedSafe. He remarked that Oviya MedSafe has addressed the knowledge and affordability deficit in the pharmaceutical industry in terms of pharmacovigilance services. He stated that DRUG DILIGENCE 2017 was organized because everyone at Oviya MedSafe felt that the best way to celebrate Oviya MedSafe’s 5th Anniversary was by sharing their knowledge with the society, especially with the next generation of pharmacovigilance professionals. He concluded by saying that although Oviya MedSafe has several clients to whom it offers professional services, evangelizing the concept of pharmacovigilance across the globe is the biggest achievement of Oviya MedSafe.

Earlier Dr V Janarthanan, Managing Director of KTVR Group Hospital and Chairman of Oviya MedSafe welcomed the gathering and the function ended with the vote of thanks proposed by Dr C J Arun Raja, Orthopaedic Surgeon at KTVR Group Hospital and Director of Oviya MedSafe.

A paper presentation contest for medical and pharmacy students was conducted on the theme of ‘Pharmacovigilance’, as part of DRUG DILIGENCE 2017. The winners and participants were awarded by the dignitaries in the valedictory function held at the end of the day. The event had been awarded 20 CME Credit Points by the Tamil Nadu Dr MGR Medical University under Category III.

DRUG DILIGENCE 2017 was organized and conducted by Coimbatore-based event management firm VHEO Ventures in knowledge partnership with Oviya MedSafe.

News & Events

  • 31

    Aug

    Oviya MedSafe – Enhancing Mentorship in Global Pharmacovigilance

    Continue Reading...
  • 31

    Jul

    Oviya MedSafe – Negotiating the Paradigm Shift in Pharmacovigilance Outsourcing

    Continue Reading...
  • 30

    Jun

    Oviya MedSafe and Pharmacovigilance Days – London Experiences & Hyderabad Expectations

    Continue Reading...
  • 31

    May

    Oviya MedSafe – Certified MedDRA Coders and Pharmacovigilance Torchbearers

    Continue Reading...
  • 30

    Apr

    Oviya MedSafe as an Innovation Strategist in Global Pharmacovigilance

    Continue Reading...
  • 31

    Mar

    Oviya MedSafe – 5 Years in Pharmacovigilance – 60th Newsletter

    Continue Reading...
  • 24

    Mar

    AIIMS Professor inaugurated DRUG DILIGENCE 2017 at Coimbatore

    Continue Reading...
  • 28

    Feb

    Oviya MedSafe – DRUG DILIGENCE 2017 and Honours from DIA & ISPOR

    Continue Reading...
  • 27

    Feb

    Drug Diligence 2017 – 17th & 18th March – Coimbatore

    Continue Reading...
  • 31

    Jan

    Oviya MedSafe – Building Pharmacovigilance Strategies & Invited Article in DIA Global Forum

    Continue Reading...
View All